Optical Imaging Techniques

Optical Imaging Techniques

The global market for Optical Imaging is projected to reach US$2.5 billion by 2025, driven by the importance of medical imaging in healthcare in disease prevention, early detection, diagnosis, and treatment. Essential in the management of all virtually all medical conditions and diseases, there is growing interest in R&D of newer and more powerful imaging technologies. Advanced imaging capabilities provide huge benefits such as early detection; better diagnosis; detailed visualization of anatomical structures; easy and faster physician understanding of disease complications; better clinical decisions; reduced risk of errors; safer in terms of medical radiation exposure; and better patient outcome. Optical medical imaging is the newest imaging technology capable of revolutionizing healthcare in ways hitherto unimagined. Defined as the use of light to visualize cellular and molecular functions in a living body, optical imaging revolves around the use of photons in light to generate images. Light of various wavelengths are used ranging from ultraviolet to near infrared. Fluorescence protein imaging has huge potential in cancer screening given its ability to accurately detect lesions, monitor tumor growth and evaluate patient response to therapy. The technology revolves round the use of endogenous or exogenous materials that illuminate when activated by an external light source.

Endoscopy is the most simple and widely used type of optical imaging that utilizes a flexible tube to deliver light to targeted organs for visualization. Demand for advanced endoscopic imaging is poised to benefit from the growing preference for minimally invasive surgeries and growing penetration of endoscopy in multiple applications such as esophagus, stomach, ulcerative colitis and Crohn’s disease, gallstones, hiatal hernia, vaginal bleeding, etc. The wide array of endoscopies available stands testimony to the ubiquity of this technology i.e. arthroscopy, bronchoscopy, colonoscopy, cystoscopy, enteroscopy, hysteroscopy, laparoscopy, laryngoscopy, mediastinoscopy and sigmoidoscopy, ureteroscopy, esophagogastroduodenoscopy and thoracoscopy. Optical Coherence Tomography (OCT) is used widely in ophthalmology and cardiology and involves the use of light waves to generate in-vivo cross sectional views of diseased tissues. The growing burden of cardiovascular diseases which currently stands at billions of dollars worldwide is a major revenue draw for OCT. Photoacoustic Imaging is also used in cancer tumor monitoring and involves delivering heat generating laser pulses to tissues that expand tissues and enable their imaging. The epidemic spread of cancer bodes well for this technology. In vivo optical imaging using fluorescence and bioluminescence is also invaluable and superior to other methods of imaging. With global cancer burden as measured by new cancer diagnosis poised to reach over 20 million per year by 2020, effective optical methods for cancer imaging will grow in prominence. Diffuse Optical Tomography (DOT) is used for imaging of the brain and involves the use of near-infrared light, which when absorbed by the neurons reveals information about the chemical compositions in the brain. The emerging field of neuroscience will offer ample market opportunities for the use of DOT in anesthesia monitoring and also monitoring psychoactive medications used to treat depression and post-traumatic stress disorder, among others. The United States and Europe represent large markets worldwide with a combined share of 70.1% of the market. China ranks as the fastest growing market with a CAGR of 15.3% over the analysis period supported by the country’s rapidly developing healthcare system under the “Healthy China 2020” initiative.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • Agfa-Gevaert Group
  • ASE Optics Europe
  • Canon U.S.A., Inc.
  • Carl-Zeiss Meditec AG
  • ChemImage Corporation
  • Cytoviva Inc.
  • Headwall Photonics, Inc.
  • Heidelberg Engineering GmbH
  • Koninklijke Philips N.V.
  • Leica Microsystems GmbH
  • Optical Imaging Ltd.
  • PerkinElmer, Inc.
  • Topcon Corporation
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
An Introduction to Optical Imaging
Optical Imaging: Current Market Scenario and Outlook
Developed Regions: Dominant Consumers of Optical Imaging Technologies
EXHIBIT 1: World Optical Imaging Market by Region: Percentage Breakdown of Revenues for Developed and Developing Regions (2019 & 2025)
Developing Regions to Spearhead Future Growth
EXHIBIT 2: World Optical Imaging Market - Geographic Regions Ranked by CAGR (Value) for 2018-2025: China, Asia-Pacific, Latin America, Middle East, Africa, Canada, USA, Europe, and Japan
Key Factors Driving Demand for Medical Imaging Services in Developing Regions
Growing Healthcare Awareness
Increased Access to Healthcare and Surge in Number of Hospitals & Clinics
Proliferation of Medical Tourism
Optical Coherence Tomography: Major Optical Imaging Technique
Robust Opportunities for Hyperspectral Imaging
Near-infrared Spectroscopy Gains Traction
Photoacoustic Tomography Set to Make Gains
2. FOCUS ON SELECT PLAYERS
Abbott Laboratories (USA)
Agfa-Gevaert Group (Belgium)
ASE Optics Europe (Spain)
Canon U.S.A., Inc. (USA)
Carl-Zeiss Meditec AG (Germany)
ChemImage Corporation (USA)
Cytoviva Inc. (USA)
Headwall Photonics, Inc. (USA)
Heidelberg Engineering GmbH (Germany)
Koninklijke Philips N.V. (Netherlands)
Leica Microsystems GmbH (Germany)
Optical Imaging Ltd. (Israel)
PerkinElmer, Inc. (USA)
Topcon Corporation (Japan)
3. MARKET TRENDS & DRIVERS
Hospitals & Clinics: Dominant Consumers of Optical Imaging Solutions
Optical Imaging Remains Highly Relevant in Research Laboratories
Rising Prominence of Optical Imaging Technologies for Pharmaceutical & Biotech Firms
Growing Investments in Healthcare & Lifescience Sectors Create Conducive Environment for Growth of Optical Imaging Market
EXHIBIT 3: World Healthcare Spending & Growth (in US$ Trillion) and % Real GDP Growth for the Years 2012 through 2018
High Growth Opportunities in Oncology Care
EXHIBIT 4: Worldwide Incidence of Cancer (2012, 2018 & 2040): Number of New Cases Diagnosed
Growing Adoption in Cardiology Applications Bodes Well
Demographic Factors Favor Growth
Market Stands to Gain from Expanding Geriatric Population
EXHIBIT 5: Global Aging Population (in Thousands) by Age Group: 1975-2050
EXHIBIT 6: Elderly Population (60+ Years) as a Percentage of Total Population (2015 & 2050)
EXHIBIT 7: Life Expectancy at Birth in Years of People in Select Countries (2017)
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Current & Future Analysis for Optical Imaging Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Optical Imaging Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Optical Imaging Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
TABLE 4: World Current & Future Analysis for Optical Coherence Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Optical Coherence Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for Optical Coherence Tomography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 7: World Current & Future Analysis for Hyperspectral Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Hyperspectral Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for Hyperspectral Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 10: World Current & Future Analysis for Near-infrared Spectroscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Near-infrared Spectroscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for Near-infrared Spectroscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 13: World Current & Future Analysis for Photoacoustic Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for Photoacoustic Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for Photoacoustic Tomography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 16: World Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 19: World Current & Future Analysis for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 21: World 15-Year Perspective for Ophthalmology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 22: World Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 23: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 24: World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 25: World Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 26: World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 27: World 15-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 28: World Current & Future Analysis for Other Therapeutic Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 29: World Historic Review for Other Therapeutic Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 30: World 15-Year Perspective for Other Therapeutic Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 31: World Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 32: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 33: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 34: World Current & Future Analysis for Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 35: World Historic Review for Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 36: World 15-Year Perspective for Research Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 37: World Current & Future Analysis for Pharma & Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 38: World Historic Review for Pharma & Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 39: World 15-Year Perspective for Pharma & Biotech by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
TABLE 40: USA Current & Future Analysis for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 41: USA Historic Review for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 42: USA 15-Year Perspective for Optical Imaging Techniques by Technique - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography for the Years 2012, 2020 & 2027
TABLE 43: USA Current & Future Analysis for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 44: USA Historic Review for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 45: USA 15-Year Perspective for Optical Imaging Techniques by Therapeutic Type - Percentage Breakdown of Value Sales for Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types for the Years 2012, 2020 & 2027
TABLE 46: USA Current & Future Analysis for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 47: USA Historic Review for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 48: USA 15-Year Perspective for Optical Imaging Techniques by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Research Laboratories and Pharma & Biotech for the Years 2012, 2020 & 2027
CANADA
TABLE 49: Canada Current & Future Analysis for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 50: Canada Historic Review for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 51: Canada 15-Year Perspective for Optical Imaging Techniques by Technique - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography for the Years 2012, 2020 & 2027
TABLE 52: Canada Current & Future Analysis for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 53: Canada Historic Review for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 54: Canada 15-Year Perspective for Optical Imaging Techniques by Therapeutic Type - Percentage Breakdown of Value Sales for Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types for the Years 2012, 2020 & 2027
TABLE 55: Canada Current & Future Analysis for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 56: Canada Historic Review for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 57: Canada 15-Year Perspective for Optical Imaging Techniques by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Research Laboratories and Pharma & Biotech for the Years 2012, 2020 & 2027
JAPAN
TABLE 58: Japan Current & Future Analysis for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 59: Japan Historic Review for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 60: Japan 15-Year Perspective for Optical Imaging Techniques by Technique - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography for the Years 2012, 2020 & 2027
TABLE 61: Japan Current & Future Analysis for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 62: Japan Historic Review for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 63: Japan 15-Year Perspective for Optical Imaging Techniques by Therapeutic Type - Percentage Breakdown of Value Sales for Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types for the Years 2012, 2020 & 2027
TABLE 64: Japan Current & Future Analysis for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 65: Japan Historic Review for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 66: Japan 15-Year Perspective for Optical Imaging Techniques by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Research Laboratories and Pharma & Biotech for the Years 2012, 2020 & 2027
CHINA
TABLE 67: China Current & Future Analysis for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 68: China Historic Review for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 69: China 15-Year Perspective for Optical Imaging Techniques by Technique - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography for the Years 2012, 2020 & 2027
TABLE 70: China Current & Future Analysis for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 71: China Historic Review for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 72: China 15-Year Perspective for Optical Imaging Techniques by Therapeutic Type - Percentage Breakdown of Value Sales for Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types for the Years 2012, 2020 & 2027
TABLE 73: China Current & Future Analysis for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 74: China Historic Review for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 75: China 15-Year Perspective for Optical Imaging Techniques by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Research Laboratories and Pharma & Biotech for the Years 2012, 2020 & 2027
EUROPE
TABLE 76: Europe Current & Future Analysis for Optical Imaging Techniques by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 77: Europe Historic Review for Optical Imaging Techniques by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 78: Europe 15-Year Perspective for Optical Imaging Techniques by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
TABLE 79: Europe Current & Future Analysis for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 80: Europe Historic Review for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 81: Europe 15-Year Perspective for Optical Imaging Techniques by Technique - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography for the Years 2012, 2020 & 2027
TABLE 82: Europe Current & Future Analysis for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 83: Europe Historic Review for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 84: Europe 15-Year Perspective for Optical Imaging Techniques by Therapeutic Type - Percentage Breakdown of Value Sales for Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types for the Years 2012, 2020 & 2027
TABLE 85: Europe Current & Future Analysis for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 86: Europe Historic Review for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 87: Europe 15-Year Perspective for Optical Imaging Techniques by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Research Laboratories and Pharma & Biotech for the Years 2012, 2020 & 2027
FRANCE
TABLE 88: France Current & Future Analysis for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 89: France Historic Review for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 90: France 15-Year Perspective for Optical Imaging Techniques by Technique - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography for the Years 2012, 2020 & 2027
TABLE 91: France Current & Future Analysis for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 92: France Historic Review for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 93: France 15-Year Perspective for Optical Imaging Techniques by Therapeutic Type - Percentage Breakdown of Value Sales for Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types for the Years 2012, 2020 & 2027
TABLE 94: France Current & Future Analysis for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 95: France Historic Review for Optical Imaging Techniques by End-Use - Hospitals & Clinics, Research Laboratories and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 96: France 15-Year Perspective for Optical Imaging Techniques by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Research Laboratories and Pharma & Biotech for the Years 2012, 2020 & 2027
GERMANY
TABLE 97: Germany Current & Future Analysis for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 98: Germany Historic Review for Optical Imaging Techniques by Technique - Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 99: Germany 15-Year Perspective for Optical Imaging Techniques by Technique - Percentage Breakdown of Value Sales for Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy and Photoacoustic Tomography for the Years 2012, 2020 & 2027
TABLE 100: Germany Current & Future Analysis for Optical Imaging Techniques by Therapeutic Type - Oncology, Ophthalmology, Neurology, Cardiology and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook